Investment Pitches

Pitch Summary:
The investment thesis for Energy Transfer LP is bearish due to several macroeconomic and company-specific factors. The company faces headwinds from weak macroeconomic indicators, such as contracting manufacturing PMI and a declining Leading Economic Index, which suggest lower volume growth. Additionally, the potential for a prolonged high-interest rate environment could increase financial strain, particularly as Energy Transfer may need to raise debt for significant capital expenditure projects like the Lake Charles and Southern Illinois Connector projects. Although the company's dividends appear safe for now, the margin of safety is diminishing, and the stock's valuation is close to its long-term fair value. Technical analysis also indicates potential underperformance relative to the broader market.

BSD Analysis:
Energy Transfer's financial health is under scrutiny as interest expenses already account for a significant portion of its EBIT. With the Federal Reserve's rate hikes likely to persist, the company's cost of capital could rise, impacting its ability to finance large-scale projects without increasing leverage. The Lake Charles project, requiring substantial investment, highlights the need for strategic partnerships to mitigate funding risks. Energy Transfer's current EV/EBITDA valuation suggests it is trading near fair value, but its discount relative to peers is consistent with historical norms. The company's technical indicators, such as a false breakout against the S&P 500, suggest further downside potential. Investors should monitor how effectively Energy Transfer manages its capital structure and funding needs, as these will be critical to maintaining dividend payouts and achieving long-term growth objectives.

Pitch Summary:
Palantir Technologies is positioned at the forefront of AI-driven data analytics, with its platforms gaining traction in both government and commercial sectors. The company's recent initiatives, such as the 'Warp Speed for Warships' program with the U.S. Navy, highlight its strategic importance in national defense. Palantir's AI-powered Foundry platform is well-suited for large-scale, complex data integration projects, which is expected to drive long-term growth and secure recurring revenue streams. Despite its high valuation, Palantir's robust growth trajectory and strategic partnerships, like the one with Accenture Federal Services, reinforce its potential for sustained earnings expansion.

BSD Analysis:
Palantir's financial performance in Q1 2025 was impressive, with a 39% year-over-year revenue increase to $884 million, driven by a 71% surge in U.S. commercial revenue. The company's profitability is also noteworthy, with a net income margin of 24% and a free cash flow margin of 42%. Palantir's balance sheet is strong, boasting $5.4 billion in cash and equivalents and virtually no debt. However, its valuation remains a concern, trading at over 408 times forward earnings, significantly higher than peers like Snowflake and Microsoft. The company's reliance on government contracts poses a risk, especially if federal budget priorities shift. Nevertheless, Palantir's strategic initiatives and partnerships, such as the Accenture collaboration, position it well for future growth. Investors should be cautious of the high valuation but can be optimistic about the company's long-term potential if it continues to execute effectively.

Pitch Summary:
International Consolidated Airlines Group experienced a significant rise in stock value, driven by strong first-quarter revenues and operating profits. The company benefited from cost efficiencies and lower fuel prices, positioning itself well in the recovering travel sector.

BSD Analysis:
The airline industry is rebounding as travel demand surges post-pandemic, with International Consolidated Airlines Group capitalizing on this trend. The company's operational improvements and strategic cost management have enhanced its profitability, as evidenced by its impressive quarterly performance. Lower fuel prices have further bolstered margins, providing a competitive edge. The broader industry context, including easing travel restrictions and increased passenger volumes, supports a positive outlook. However, investors should remain cautious of potential volatility in fuel prices and geopolitical risks that could impact international travel.

Pitch Summary:
Kandi Technologies faces significant challenges that make it an unattractive investment. The company is heavily exposed to tariffs, suffers from large operational losses, and lacks transparency in its financial disclosures. Despite its presence in the US market and a seemingly attractive valuation based on book value, the volatility in its financials and customer base, coupled with a lack of profitability, make it difficult to justify an investment.

BSD Analysis:
Kandi Technologies operates in a highly competitive and rapidly evolving electric vehicle market. The company's financials are characterized by high volatility, with significant fluctuations in revenue and customer concentration. This instability is compounded by a lack of detailed financial disclosures, making it challenging to assess the company's true financial health. Kandi's reliance on a single supplier for a substantial portion of its purchases raises concerns about supply chain risks. Furthermore, the company's inability to generate consistent operating profits and its exposure to geopolitical risks, such as US-China trade tensions, add to its investment risks. While the company's equity appears undervalued compared to its market capitalization, the lack of cash returns to shareholders and the complexity of its financials undermine the potential for a deep value investment thesis. Investors should approach Kandi Technologies with caution, given the significant uncertainties surrounding its business model and financial stability.

Pitch Summary:
Klaviyo is positioned as a strong investment due to its robust revenue growth, impressive net revenue retention, and strategic expansion into international markets. The company's prudent guidance for Q2 2025 suggests potential outperformance, supported by its momentum in the EMEA and APAC regions and its success in attracting larger enterprise clients. Despite macroeconomic uncertainties, Klaviyo's valuation remains attractive compared to peers, offering a compelling opportunity for long-term investors.

BSD Analysis:
Klaviyo's year-over-year revenue growth of 33% in Q1 2025, alongside a net revenue retention rate of 108%, underscores its strong market position. The company's strategic focus on international expansion, with 42% revenue growth in EMEA and APAC, highlights its potential to capture a larger share of the global market. Klaviyo's move upstream to attract mid-market and enterprise clients, evidenced by a 40% increase in customers generating over $50K in ARR, enhances revenue stability and reduces reliance on the cyclical ecommerce sector. The valuation gap with HubSpot, despite Klaviyo's superior growth metrics, suggests room for multiple expansion. However, the dependency on Shopify remains a risk, with the partnership's future beyond 2029 uncertain. Investors should monitor Klaviyo's ability to diversify its platform integrations to mitigate this risk.

Pitch Summary:
Palantir is positioned as a central player in the enterprise AI landscape, with its software being increasingly adopted by Fortune 500 companies and government agencies. The company's robust growth in commercial customer base and deal velocity, alongside its strong Rule of 40 score, suggests a sustainable competitive advantage. Despite high valuations, Palantir's strategic role in AI infrastructure and its consistent financial performance underpin a bullish outlook.

BSD Analysis:
Palantir's valuation, trading at a 92x forward EV/Sales multiple, reflects its perceived status as a hyper-growth company. The company's ability to surpass EPS estimates in 7 of the last 8 quarters and maintain a high Rule of 40 score indicates operational efficiency and growth potential. Institutional investors have shown increased confidence, as evidenced by significant position builds by pensions and hedge funds. However, the high valuation assumes flawless execution, and any macroeconomic slowdown or geopolitical shifts could impact its growth trajectory. The company's deep integration into defense and commercial sectors, while a strength, also exposes it to geopolitical and reputational risks. Overall, Palantir's strategic positioning in AI and its expanding commercial footprint support a bullish thesis, but investors should remain vigilant of potential downside risks.

Pitch Summary:
Invesco Ltd. is undergoing strategic changes, including the conversion of its QQQ fund and a significant agreement with MassMutual, which could enhance its financial position and attract new investors. The company has also increased its dividend and repurchased shares, indicating a commitment to shareholder returns. However, potential risks such as investment restrictions in foreign markets, interest rate fluctuations, and challenges in achieving inorganic growth could impact future performance.

BSD Analysis:
Invesco's strategic initiatives, such as the QQQ fund conversion and the MassMutual agreement, are expected to bolster its balance sheet and potentially increase its market valuation. The firm's current valuation at 8.9x 2028 EPS suggests it is undervalued compared to industry peers, providing a potential upside if earnings exceed expectations. However, the company's exposure to global markets introduces risks related to foreign exchange fluctuations and regulatory changes, particularly in regions like the EU and Asia. Additionally, the investment management industry is sensitive to market cycles, and any downturn could adversely affect Invesco's revenue and profitability. The firm's historical reliance on acquisitions for growth may face headwinds due to regulatory scrutiny, potentially limiting future expansion opportunities. Overall, while Invesco's strategic moves are promising, the external challenges warrant a cautious outlook.

Pitch Summary:
Nvidia stands to benefit significantly from the ongoing AI revolution, as its GPUs are critical for AI model training and inferencing. The exponential increase in AI workloads, driven by the adoption of reasoning models and the democratization of AI capabilities, is expected to drive substantial revenue growth for Nvidia.

BSD Analysis:
Nvidia's position as a leader in AI hardware makes it a key beneficiary of the AI boom. The company's GPUs are essential for processing the massive amounts of data required by advanced AI models. With hyperscalers like Microsoft, Alphabet, and Amazon increasing their capital expenditures to expand AI infrastructure, Nvidia is poised for significant revenue growth. Consensus estimates suggest that Nvidia's revenue could grow by over 50% in 2025, driven by the increased demand for AI processing power. Additionally, Nvidia's strategic partnerships and continued innovation in AI hardware position it well to capture a substantial share of the growing AI market. The company's focus on developing cutting-edge AI solutions and its strong market presence make it a compelling investment opportunity in the technology sector.

Pitch Summary:
FinVolution Group has shown significant recovery since its initial poor performance post-IPO, driven by improved navigation of regulatory challenges and strong operational metrics. The company is experiencing rapid adoption in its international markets, and its revenue growth is rebounding with rising profitability. Despite macroeconomic headwinds, the company's operational resilience and strong full-year guidance suggest that its current P/S ratio indicates material undervaluation. Therefore, the stock is initiated with a buy rating.

BSD Analysis:
FinVolution's Q1 2025 results highlight a robust growth trajectory, with revenues increasing by 10% year-over-year to RMB3.481 billion. The company's operational metrics, such as a 11.7% increase in cumulative registered users in China and a 45.1% rise internationally, underscore its expanding market presence. Despite a concerning rise in expenses, particularly in sales and marketing and general administrative costs, the company's profitability is on an upward trend, with non-GAAP net profit growing 37% YoY. The P/S ratio, although higher than historical averages, remains significantly discounted compared to the Financials sector median, suggesting undervaluation. Given the company's strong operational performance and growth potential, particularly in international markets, FinVolution is well-positioned for future success, albeit with some regulatory risks inherent to its Chinese operations.

Pitch Summary:
Silvercorp Metals presents a compelling investment opportunity due to its strong financial position, attractive valuation metrics, and robust margins compared to its peers in the silver mining industry. Despite recent underperformance, the company has demonstrated consistent revenue growth and maintained solid margins, even as silver prices fluctuated. Its strategic reinvestment into expanding production and reducing costs positions it well for future growth. The stock appears undervalued, with significant upside potential if the company achieves its revenue targets and market sentiment around China improves.

BSD Analysis:
Silvercorp Metals stands out in the silver mining sector with its superior margins and valuation metrics. The company's decision to reinvest profits into expansion rather than dividends or buybacks has positioned it for significant growth, with a projected revenue increase of over 100% by FY2028. The company's financial health is robust, with cash and cash equivalents exceeding total liabilities, and a market cap of approximately $967 million. However, its heavy reliance on Chinese operations introduces geopolitical risks, particularly given China's history of market interventions and recent policy changes affecting the mining sector. Despite these risks, the company's strategic diversification efforts and the potential for rate cuts to boost economic activity and demand for silver make it an attractive investment. If Silvercorp can capitalize on its growth initiatives and the market's perception of Chinese assets improves, the stock could see substantial appreciation, potentially doubling in value if free cash flow projections are realized.

Pitch Summary:
Silvercorp Metals Inc. is currently rated as a Hold due to its recent strong performance and the potential for a price decline before a new upward momentum can be established. The company has shown robust financial results and operational growth, driven by rising silver prices and efficient mining operations. However, the stock price may not be attractive at current levels, and investors are advised to wait for potential dips to initiate or add to positions.

BSD Analysis:
Silvercorp Metals has demonstrated a strong financial performance with a 76% year-over-year revenue increase in Q4 2025, driven by rising silver prices and efficient production. The company's strategic focus on generating free cash flow and organic growth through drilling and acquisitions supports its long-term value creation. With a solid balance sheet, including a low net debt to EBITDA ratio of 1.9, Silvercorp is well-positioned to finance its growth initiatives, such as the development of the El Domo project in Ecuador. The company's operations in China benefit from the country's position as the second-largest silver producer globally, providing a favorable backdrop for Silvercorp's growth. However, potential headwinds include the impact of U.S. monetary policy on precious metals and the stock's high beta of 1.84, which could lead to volatility. Investors should monitor silver price trends and macroeconomic factors, such as interest rates, to identify optimal entry points.

Pitch Summary:
Amazon has significantly enhanced its operational efficiency by integrating over one million robots into its warehouse operations, rivaling the number of human workers. This automation has increased throughput per employee twentyfold, from 175 packages in 2015 to nearly 3,870 in 2025. The company's strategic focus on robotics and AI has not only accelerated order processing but also improved revenue per employee, positioning Amazon as a leader in logistics technology.

BSD Analysis:
Amazon's strategic investment in robotics and AI underscores its commitment to maintaining a competitive edge in the e-commerce sector. The integration of advanced automation technologies has allowed Amazon to reduce its labor footprint while significantly increasing operational efficiency. This shift is reflected in the company's financial performance, with a notable increase in revenue per employee. As Amazon continues to innovate, its focus on AI-driven logistics could further enhance its market position. Additionally, the company's cloud computing division, AWS, remains a critical growth driver, contributing significantly to Amazon's overall profitability. With the ongoing expansion of AI capabilities, Amazon is well-positioned to capitalize on emerging opportunities in both e-commerce and cloud services, potentially driving long-term shareholder value.

Pitch Summary:
Advanced Micro Devices (AMD) is strategically positioned to capitalize on the growing demand for AI and data center infrastructure. With a robust product lineup, including the energy-efficient MI300X GPU, AMD is poised to capture market share from competitors like Nvidia. The company's recent approval to export AI GPUs to China further expands its total addressable market, offering significant growth potential. AMD's strong revenue growth in the AI and data center segments, coupled with its competitive pricing and innovative technology, makes it a compelling investment opportunity.

BSD Analysis:
AMD's recent 36% year-over-year revenue growth in Q1 FY 2025, driven by a 57% increase in data center sales, underscores its strong market position. The company's forward PEG ratio of 1.31x, compared to the sector median of 1.88x, indicates a 30.10% discount, suggesting that the market has not fully priced in AMD's growth prospects. With a forward revenue growth rate of 18.78%, significantly higher than the sector median of 7.17%, AMD is well-positioned for continued expansion. The approval to export AI GPUs to China opens up a substantial market, projected to reach $1.4 trillion by 2030. However, geopolitical risks and potential export restrictions remain key concerns. Overall, AMD's strategic focus on AI-specific silicon and its ability to provide a vertically integrated platform differentiate it from competitors, positioning it as a leader in the evolving AI landscape.

Pitch Summary:
Humana Inc. is currently facing significant challenges, including a substantial drop in its Medicare plan ratings and a legal setback related to these ratings. The company's earnings per share are projected to decline in the near term, and its profit margins are under pressure. While Humana is expanding its CenterWell clinics and has exited its Employer Group health business, these moves have not yet translated into improved financial performance. Given these challenges, the stock is not a compelling buy at the moment, and patience is advised.

BSD Analysis:
Humana's current valuation, trading at approximately 13.5 times next year's earnings, does not offer a significant discount compared to its peers like UnitedHealth Group, Cigna, and Elevance Health, which have stronger profitability metrics. The company's net margin is just above 1%, lagging behind competitors who maintain higher margins. Humana's dividend yield of 1.6% is also less attractive compared to its peers. The company's debt-to-equity ratio is relatively high, and its cash flow is shrinking, which limits its financial flexibility. For investors seeking value, Cigna and Elevance Health present more attractive opportunities with better growth prospects and profitability. Humana's path to recovery hinges on resolving its Medicare ratings issue and improving operational efficiency, but these are long-term challenges that require careful execution by management.

Pitch Summary:
LuxExperience is positioned to capitalize on the rapid growth of the online luxury market, which is projected to double by 2030. The company's recent acquisition of YOOX NET-A-PORTER significantly expands its customer base and product offerings, positioning it to achieve ambitious revenue and EBITDA targets. Despite current profitability challenges, the company's strategic focus on high-margin full-price sales and operational synergies from the acquisition provide a path to improved financial performance. The stock is undervalued compared to peers, offering substantial upside potential.

BSD Analysis:
LuxExperience's strategic acquisition of YOOX NET-A-PORTER is a bold move to capture a larger share of the burgeoning online luxury market, expected to grow at a 13% CAGR. The company's diversified geographic presence mitigates regional risks, unlike competitors heavily reliant on specific markets. LuxExperience's high average retail prices and focus on curated luxury offerings enhance its margin potential. However, the integration of YOOX NET-A-PORTER presents challenges, as both the luxury and off-price segments currently underperform. The company's ability to streamline operations and improve margins will be crucial. With a P/S ratio significantly lower than peers like Frasers Group and Revolve Group, LuxExperience's stock offers a compelling value proposition. The company's cash reserves provide a buffer to execute its turnaround strategy, aiming for a 50% upside if successful.

Pitch Summary:
Lyell Immunopharma is advancing its CAR-T cell therapy, LYL314, targeting patients with large B-cell lymphoma (LBCL) who are in the second or third line of treatment and have not previously received CAR-T therapy. The company has initiated a phase 3 trial for third-line patients and plans to start another for second-line patients in early 2026. Despite promising phase 1/2 data showing high response rates, the stock is rated 'Hold' due to the need for further validation in ongoing trials.

BSD Analysis:
Lyell Immunopharma's strategic pivot to focus on LYL314 follows a pipeline restructuring and acquisition of ImmPACT Bio. The company's dual-targeting CD19/CD20 CAR-T therapy aims to improve persistence and reduce exhaustion compared to existing treatments. The phase 1/2 trial showed an 88% objective response rate and a 72% complete response rate in third-line patients, with durable responses in a majority. Financially, Lyell is well-positioned with $330.1 million in cash and marketable securities, sufficient to fund operations into 2027. However, competition from established CAR-T therapies like YESCARTA, Breyanzi, and KYMRIAH poses a significant challenge. The success of LYL314 hinges on its ability to demonstrate superior efficacy and safety in phase 3 trials, which could potentially disrupt the current market landscape if successful.

Pitch Summary:
Micron Technology is positioned to benefit from the growing demand for high-bandwidth memory (HBM) driven by AI and ASIC applications. Despite recent market volatility and concerns over memory demand, Micron's focus on HBM, which is fully booked for the year, and its strategic partnerships with major tech companies like AMD and NVIDIA, provide a strong growth catalyst. The company's valuation remains attractive compared to peers, and its revenue mix is shifting towards more profitable DRAM products, which account for a significant portion of its sales.

BSD Analysis:
Micron's strategic pivot towards HBM is timely, given the anticipated surge in demand from AI and ASIC markets. The company's HBM3E and upcoming HBM4E products are set to capture a significant share of this expanding market, with potential clients including Amazon and Broadcom. Despite concerns about potential oversupply, Micron's competitive positioning and technological advancements in HBM could mitigate these risks. The company's current P/E ratio of 14.62x is below the peer average, suggesting undervaluation. However, investors should remain cautious of the cyclical nature of the memory industry and monitor spot price trends closely. Micron's ability to maintain its market share in both DRAM and HBM will be crucial for sustaining its growth trajectory.

Pitch Summary:
Talen Energy Corporation is strategically positioned to benefit from rising electricity demand and prices in the U.S. due to its aggressive commercial strategy and recent acquisitions. The company has expanded its capacity by acquiring power plants in Ohio and Pennsylvania, which is expected to enhance its operating leverage. Talen's approach of maintaining unhedged capacity allows it to capitalize on price increases, although it also introduces some risk. The upsized PPA with Amazon further strengthens its future earnings potential, making Talen a compelling investment opportunity.

BSD Analysis:
Talen Energy's recent acquisitions and strategic partnerships, such as the expanded PPA with Amazon, position it to significantly increase its EBITDA by 2032. The company's decision to keep a portion of its capacity unhedged is a calculated risk that could yield substantial returns if electricity prices continue to rise. However, the reliance on natural gas, with its potential price volatility, poses a risk to margins. The company's valuation has been re-rated upwards, reflecting its growth prospects and strategic moves. The consensus price target of US$398 suggests a P/E of 19x for 2026, indicating confidence in Talen's ability to deliver on its growth strategy. Investors should monitor natural gas price trends and regulatory developments, as these could impact Talen's profitability and operational strategy.

Pitch Summary:
@realroseceline argues that DLocal is evolving from a cross-border payments processor into a deeper financial infrastructure platform for emerging markets. While the business is known for serving global enterprises like Amazon and Meta, the pitch highlights that each transaction also provides visibility into millions of small merchants and gig workers—creating a rich underwriting dataset. The author suggests that DLO is quietly exploring SMB lending using this proprietary data, effectively bypassing the weak credit infrastructure typical in Latin America, Africa, and Asia. Leadership under Pedro, who helped build Mercado Pago at MELI, is presented as a major strategic advantage given his experience building at-scale fintech ecosystems. Beyond lending, the company is experimenting with stablecoins, AI-driven fraud tools, and biometric authentication, which could reduce friction and increase platform stickiness. The broader thesis is that DLocal is laying rails for a more comprehensive financial platform, positioning the company to expand far beyond payments in its next stage of growth.

BSD Analysis:
DLocal occupies a valuable position as a cross-border payments orchestrator in emerging markets, where regulatory fragmentation and infrastructure gaps create natural barriers to entry. Its visibility into transaction-level merchant activity provides a differentiated data asset that can extend logically into credit, though underwriting risk in volatile economies remains a core challenge. The move toward stablecoin-based settlement could materially lower costs and improve speed, but regulatory acceptance will determine adoption. Leadership with a Mercado Pago pedigree increases the credibility of a multi-product expansion strategy, though MELI’s success also highlights the operational complexity of scaling fintech ecosystems. The greatest strategic risk is balancing innovation with regulatory compliance across dozens of jurisdictions. Margin durability will depend on operational discipline as the company introduces new services that may initially dilute profitability. If executed well, DLocal could transition from a niche processor into a broader financial infrastructure provider, but the valuation will need to reflect both the optionality and the heightened execution risk.

Actual Post Content:
$DLO Might Be Playing a Deeper Game Most people see $DLO as a payments company helping global giants like $AMZN and $META move money in tricky places like Brazil, India, or Nigeria. On the surface, it looks like a business built for large enterprise clients. But if you zoom in, something interesting is happening. Behind every transaction $DLO processes, there’s a small merchant, a gig worker, or a creator in these markets. They’re not $DLO direct clients, but they’re in the flow. And that flow might lead to a long term opportunity because $DLO is collecting all that valuable transaction data. $DLO is quietly exploring lending to small and medium sized businesses in emerging markets. They already see the transaction data. They know which merchants have steady volume and who’s growing. That makes it easier to underwrite loans without relying on traditional credit systems, which often don’t work well in these regions. What makes this even more compelling is the guy running the show, Pedro helped build Mercado Pago at $MELI, which is probably the best fintech product ever created in Latin America. He knows this space better than almost anyone, and that gives $DLO a huge edge in seeing what’s possible. And he built a very similar product at $MELI which is still thriving today. The lending piece is just one layer. $DLO is also experimenting with stablecoins to bypass outdated systems like SWIFT and move money faster and cheaper across borders. They’re investing in things like AI fraud detection and even biometric authentication to future proof their infrastructure. It’s not flashy and most people aren’t talking about it, but the direction is clear. They’re not just processing payments. They’re quietly building the rails. The more useful they become to local economies, the more valuable they get. I think in the next “act”, we’ll see $DLO evolve a lot more, with Pedro diversifying the business the way Vlad did with $HOOD. It started with stock trading, but now $HOOD has credit cards, crypto, and more. I wouldn’t be surprised if Pedro diversifies $DLO beyond just payments. 🌹

URL: https://x.com/realroseceline/status/1947397035059253530

Pitch Summary:
@A_May_MD lays out the setup for Abivax ahead of its pivotal Phase 3 ulcerative colitis readout, emphasizing that the market has deeply discounted the drug’s probability of success. The company’s poor historical execution, a disastrous IPO during an XBI bottom, and skepticism around the mechanism of action have contributed to bearish sentiment. Despite this, the author argues that investors may be overlooking the strength of the broader clinical dataset, especially maintenance and pooled Phase 2 results that suggest higher drug activity than the weak P2b remission endpoint implies. He highlights several common bear arguments—an unclear mechanism, inverse dose responses, and mediocre induction remission—as misunderstandings or statistical artifacts. The real opportunity, he suggests, lies in the sharp skew of outcomes: meaningful downside but potentially massive upside if the August readout is positive. Overall, he believes the market is pricing failure as the base case, creating an attractive asymmetric setup.

BSD Analysis:
ABVX represents a classic asymmetric biotech event-driven setup where market pessimism stems largely from historical mismanagement, poor communications, and an unclear mechanistic narrative rather than the full weight of the clinical evidence. While the P2b results contain red flags—such as an inverse dose response and weaker remission rates—other data sources, including long-term OLE continuation rates and the P2a/P2b pooled analysis, support meaningful drug activity. The comparison with Zeposia OLE persistence is particularly notable, suggesting the compound may have stronger real-world durability than surface-level data indicate. Still, the Phase 3 induction remission endpoint is a high bar and has historically been a graveyard for many UC drugs, adding genuine risk. The company’s need for capital and history of execution errors also elevate uncertainty. If the trial succeeds, ABVX could transition from a discounted microcap to a validated UC player, but failure likely pushes the equity toward optionality value only. Investors must weigh statistical nuance against meaningful binary risk, making position sizing crucial.

Actual Post Content:
Slide 1⃣: Overview of $ABVX and its past. $ABVX is a French biotech that’s been developing a drug called Obefazimod for years. It was initially studied in HIV and later COVID, but has been repurposed for treating Ulcerative Colitis (UC). The company has historically struggled with poor management as well as an EU-exclusive listing that limited access to capital. More recently, they got new leadership and launched a US IPO, but it could not have possibly come at a worse time, occurring in October 2023 within hours of an $XBI rock-bottom of $63.85. The stock has never really recovered from the busted IPO that it was limping into in the first place, and the market has posed a lot of bear theses pointing to the drug failing its upcoming P3 readout. $ABVX has a make or break readout in ulcerative colitis coming in August. The upside/downside skew is as wide as any I’ve ever seen, and the market is VERY skeptical that this little French company even has a chance to succeed. My impression is that the consensus opinion has been that $ABVX will flat out fail in the upcoming P3 induction readout. Let’s review some of these bear points in the next slide. Slide 2⃣: Why is $ABVX so cheap?! Overview of main bear theses.

URL: https://x.com/a_may_md/status/1947288945144021420